The value of niche is in the customer that a niche manufacturer brings through the door. Sometimes it’s measured in incremental opportunity, such as a prophylactic acne offering among a sea of acne treatments. And sometimes it’s measured in what happens if that niche brand is not on the shelf, driving the customer to another retail outlet. That value doesn’t change in a tough economy, but the factors that establish whether or not a niche manufacturer ever gets to the shelf, and stays on that shelf, do. There are two significant challenges for niche in today’s economic climate — SKU rationalization and the availability of capital. Click below to download the PDF of The 2009 Annual Niche Brands/Broker Report.
The need to bridge the gap between the pharmacy counter and the rest of the retail operation is generating more discussion across the industry at a time of changing consumer attitudes and growing competition from a wider range of retailers — both brick-and-mortar and virtual. Read more
Chronic care management has become an all-consuming topic for retail pharmacy. It has moved beyond a niche industry topic to a high-profile, national conversation that involves healthcare costs, government policy, emerging technologies and, most importantly, daily life for millions of consumers. Read more
The DSN PoweRx list represents nearly 80% of the total retail pharmacy business — including more than $250 billion in pharmacy sales and nearly 59,000 pharmacies. And with the rise of more consumer-centered health care, they are creating innovative programs and entering healthcare partnerships to move beyond dispensing and expand their role in the U.S. healthcare delivery system. Read more
Industry leaders talk soulful brands, doing good and operating with purpose at the third annual New General Market Summit. In this special report, DSN highlights the big ideas and best practices that emerged from the event.